These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 24679996

  • 1. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V, Bittsansky M, Ondrejka I, Dobrota D.
    Psychiatry Res; 2014 Apr 30; 222(1-2):75-83. PubMed ID: 24679996
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series.
    Carrey N, MacMaster FP, Sparkes SJ, Khan SC, Kusumakar V.
    J Child Adolesc Psychopharmacol; 2002 Apr 30; 12(4):331-6. PubMed ID: 12625993
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association of adult attention deficit hyperactivity disorder subtypes and response to methylphenidate HCL treatment: A magnetic resonance spectroscopy study.
    Unal GA, Kenar AN, Herken H, Kiroglu Y.
    Neurosci Lett; 2015 Sep 14; 604():188-92. PubMed ID: 26257254
    [Abstract] [Full Text] [Related]

  • 7. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
    Ni HC, Shang CY, Gau SS, Lin YJ, Huang HC, Yang LK.
    Int J Neuropsychopharmacol; 2013 Oct 14; 16(9):1959-73. PubMed ID: 23672818
    [Abstract] [Full Text] [Related]

  • 8. Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions.
    Yildiz O, Sismanlar SG, Memik NC, Karakaya I, Agaoglu B.
    Child Psychiatry Hum Dev; 2011 Jun 14; 42(3):257-69. PubMed ID: 21165694
    [Abstract] [Full Text] [Related]

  • 9. Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naïve children with attention deficit/hyperactivity disorder: A counting Stroop functional MRI study.
    Chou TL, Chia S, Shang CY, Gau SS.
    Eur Neuropsychopharmacol; 2015 Dec 14; 25(12):2300-10. PubMed ID: 26409297
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
    Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer MJ, Simmons A, Rubia K.
    Cereb Cortex; 2014 Jan 14; 24(1):174-85. PubMed ID: 23048018
    [Abstract] [Full Text] [Related]

  • 13. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.
    Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH.
    J Child Adolesc Psychopharmacol; 2007 Feb 14; 17(1):11-7. PubMed ID: 17343550
    [Abstract] [Full Text] [Related]

  • 14. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands.
    Sasané R, Hodgkins P, Meijer W.
    Curr Med Res Opin; 2010 Nov 14; 26(11):2565-74. PubMed ID: 20863165
    [Abstract] [Full Text] [Related]

  • 15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.
    Clin Ther; 2007 Jun 14; 29(6):1168-77. PubMed ID: 17692731
    [Abstract] [Full Text] [Related]

  • 16. Effects of methylphenidate treatment on the cerebellum in adult attention-deficit hyperactivity disorder: a magnetic resonance spectroscopy study.
    Inci Kenar AN, Unal GA, Kiroglu Y, Herken H.
    Eur Rev Med Pharmacol Sci; 2017 Jan 14; 21(2):383-388. PubMed ID: 28165547
    [Abstract] [Full Text] [Related]

  • 17. Differential Treatment Effects of Methylphenidate and Atomoxetine on Executive Functions in Children with Attention-Deficit/Hyperactivity Disorder.
    Wu CS, Shang CY, Lin HY, Gau SS.
    J Child Adolesc Psychopharmacol; 2021 Apr 14; 31(3):187-196. PubMed ID: 33890819
    [Abstract] [Full Text] [Related]

  • 18. Fronto-Cerebellar Neurometabolite Alterations After Methylphenidate in Children and Adolescents With ADHD: A Proton Magnetic Resonance Spectroscopy Study.
    Bakhshi S, Tehrani-Doost M, Batouli SAH.
    J Atten Disord; 2023 Feb 14; 27(4):410-422. PubMed ID: 36635897
    [Abstract] [Full Text] [Related]

  • 19. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M, Munda B, Svab V, Locatelli I.
    J Affect Disord; 2015 Jun 01; 178():149-59. PubMed ID: 25813457
    [Abstract] [Full Text] [Related]

  • 20. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K.
    Psychol Med; 2014 Feb 01; 44(3):633-46. PubMed ID: 23597077
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.